Creson J R, Lim L C, Glowacki N J, Callister S M, Schell R F
Wisconsin State Laboratory of Hygiene, University of Wisconsin, Madison 53706, USA.
Clin Diagn Lab Immunol. 1996 Mar;3(2):184-90. doi: 10.1128/cdli.3.2.184-190.1996.
Borreliacidal antibodies participate in the resolution of Lyme disease by clearing Borrelia burgdorferi sensu lato from the host. Detection of borreliacidal antibodies is also valuable for determination of the specific serodiagnosis of Lyme disease. We show in this work that antibody detected by the borreliacidal antibody test did not correlate with antibody detected by the indirect fluorescent-antibody assay or Western immunoblotting. Detection of borreliacidal antibody decreased with elimination of the spirochete from the host in the presence or absence of therapy. By contrast, the antibody responses detected by the indirect fluorescent-antibody assay or Western immunoblotting remained elevated or continued to expand, respectively. This suggests that the borreliacidal antibody test is a prognostic indicator for clearance of the spirochete. Additional investigations with humans are needed to confirm the prognostic potential of the borreliacidal antibody test.
杀疏螺旋体抗体通过清除宿主体内的伯氏疏螺旋体狭义种参与莱姆病的消退。检测杀疏螺旋体抗体对于莱姆病的特异性血清学诊断也很有价值。我们在这项研究中表明,杀疏螺旋体抗体试验检测到的抗体与间接荧光抗体试验或Western免疫印迹检测到的抗体不相关。在有或没有治疗的情况下,随着宿主体内螺旋体的清除,杀疏螺旋体抗体的检测减少。相比之下,间接荧光抗体试验或Western免疫印迹检测到的抗体反应分别保持升高或继续扩大。这表明杀疏螺旋体抗体试验是螺旋体清除的一个预后指标。需要对人类进行更多研究以证实杀疏螺旋体抗体试验的预后潜力。